Measuring the strength of national pharmaceutical intellectual property regimes: Creating a new pharmaceutical IP index

Meir Perez Pugatch

doi:10.1111/j.1422-2213.2006.00282.x

Measuring the strength of national pharmaceutical intellectual property regimes: Creating a new pharmaceutical IP index

Meir Perez Pugatch

School of Public Health

Research output: Contribution to journal › Article › peer-review

Abstract

This article proposes a new index that seeks to measure the national strength of the pharmaceutical intellectual property environment of a given country. This Pharmaceutical IP Index focuses on four countries: the US, the UK, Singapore and Israel.

Original language	English
Pages (from-to)	373-391
Number of pages	19
Journal	The Journal of World Intellectual Property
Volume	9
Issue number	4
DOIs	https://doi.org/10.1111/j.1422-2213.2006.00282.x
State	Published - 2006

Access to Document

10.1111/j.1422-2213.2006.00282.x

Cite this

@article{7adf7217b93e4764a1084763c07edb48,

title = "Measuring the strength of national pharmaceutical intellectual property regimes: Creating a new pharmaceutical IP index",

abstract = "This article proposes a new index that seeks to measure the national strength of the pharmaceutical intellectual property environment of a given country. This Pharmaceutical IP Index focuses on four countries: the US, the UK, Singapore and Israel.",

author = "Pugatch, {Meir Perez}",

year = "2006",

doi = "10.1111/j.1422-2213.2006.00282.x",

language = "English",

volume = "9",

pages = "373--391",

journal = "The Journal of World Intellectual Property",

publisher = "Wiley Online Library",

number = "4",

}

TY - JOUR

T1 - Measuring the strength of national pharmaceutical intellectual property regimes: Creating a new pharmaceutical IP index

AU - Pugatch, Meir Perez

PY - 2006

Y1 - 2006

N2 - This article proposes a new index that seeks to measure the national strength of the pharmaceutical intellectual property environment of a given country. This Pharmaceutical IP Index focuses on four countries: the US, the UK, Singapore and Israel.

AB - This article proposes a new index that seeks to measure the national strength of the pharmaceutical intellectual property environment of a given country. This Pharmaceutical IP Index focuses on four countries: the US, the UK, Singapore and Israel.

U2 - 10.1111/j.1422-2213.2006.00282.x

DO - 10.1111/j.1422-2213.2006.00282.x

M3 - Article

VL - 9

SP - 373

EP - 391

JO - The Journal of World Intellectual Property

JF - The Journal of World Intellectual Property

IS - 4

ER -

Measuring the strength of national pharmaceutical intellectual property regimes: Creating a new pharmaceutical IP index

Abstract

Access to Document

Fingerprint

Cite this